[HTML][HTML] MicroRNAs in the prognosis and therapy of colorectal cancer: From bench to bedside

KKW To, CWS Tong, M Wu… - World journal of …, 2018 - ncbi.nlm.nih.gov
MicroRNAs (miRNAs) are small, single-stranded, noncoding RNAs that can post-
transcriptionally regulate the expression of various oncogenes and tumor suppressor genes …

[HTML][HTML] Roles of the canonical myomiRs miR-1,-133 and-206 in cell development and disease

KR Mitchelson, WY Qin - World journal of biological chemistry, 2015 - ncbi.nlm.nih.gov
MicroRNAs are small non-coding RNAs that participate in different biological processes,
providing subtle combinational regulation of cellular pathways, often by regulating …

The role of hypoxia-induced miR-210 in cancer progression

K Dang, KA Myers - International journal of molecular sciences, 2015 - mdpi.com
Prolonged hypoxia, the event of insufficient oxygen, is known to upregulate tumor
development and growth by promoting the formation of a neoplastic environment. The recent …

[HTML][HTML] MicroRNAs as novel biomarkers for colorectal cancer: New outlooks

N Shirafkan, B Mansoori, A Mohammadi… - Biomedicine & …, 2018 - Elsevier
Colorectal cancer is one of the most prevalent cancers with high mortality in the world.
MicroRNAs are a class of small non-coding RNAs that regulate gene expression through …

MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer

L Cekaite, PW Eide, GE Lind, RI Skotheim… - Oncotarget, 2015 - pmc.ncbi.nlm.nih.gov
Gene expression is in part regulated by microRNAs (miRNAs). This review summarizes the
current knowledge of miRNAs in colorectal cancer (CRC); their role as growth regulators, the …

Circulating miRNA as biomarkers for colorectal cancer diagnosis and liver metastasis

FJ Nassar, ZS Msheik, MM Itani, RE Helou, R Hadla… - Diagnostics, 2021 - mdpi.com
Colorectal cancer (CRC) is the second leading cause of cancer deaths worldwide. Stage IV
CRC patients have poor prognosis with a five-year survival rate of 14%. Liver metastasis is …

Tenascin C in colorectal cancer stroma is a predictive marker for liver metastasis and is a potent target of miR-198 as identified by microRNA analysis

T Murakami, H Kikuchi, H Ishimatsu, I Iino… - British journal of …, 2017 - nature.com
Background: Tumour stroma has important roles in the development of colorectal cancer
(CRC) metastasis. We aimed to clarify the roles of microRNAs (miRNAs) and their target …

[PDF][PDF] MicroRNAs associated with small bowel neuroendocrine tumours and their metastases

HC Miller, AE Frampton, A Malczewska… - Endocr Relat …, 2016 - academia.edu
Novel molecular analytes are needed in small bowel neuroendocrine tumours (SBNETs) to
better determine disease aggressiveness and predict treatment response. In this study, we …

Investigating genomic, proteomic, and post-transcriptional regulation profiles in colorectal cancer: a comparative study between primary tumors and associated …

H Ham-Karim, O Negm, N Ahmad, M Ilyas - Cancer Cell International, 2023 - Springer
Introduction Approximately 50% of patients with primary colorectal carcinoma develop liver
metastases. This study investigates the possible molecular discrepancies between primary …

Prediction of response to anti-angiogenic treatment for advanced colorectal cancer patients: From biological factors to functional imaging

G Corrias, E Lai, P Ziranu, S Mariani, C Donisi, N Liscia… - Cancers, 2024 - mdpi.com
Simple Summary In this review, we aim to analyze the molecular bases of angiogenesis in
metastatic colorectal cancer (mCRC) and to provide an overview of potential predictive …